62
Growth Score in past quarter
pts
Heat Score 62 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
291329
Pledge Therapeutics is a biotech firm that develops novel compounds for therapeutic targets using a unique discovery platform.
- Ali Munawar: Chief Executive Officer and FounderPast Role: Novira Therapeutics, CEO & Founder
About the Company
Pledge Therapeutics is a biotechnology company that focuses on the development of novel and clinically relevant compounds for therapeutic targets. The company's discovery platform is designed to create groundbreaking medicines for targets that have previously been out of therapeutic reach. The team at Pledge Therapeutics has a diverse range of
experience, including building and exiting start-ups, advancing multiple drugs into the clinic, and holding inventor status on FDA approved drugs. The company's strategy involves a combination of operations, partnerships, and research, making it a vital player in the biotechnology industry.